VolitionRx
(NYSEMKT) VNRX
VolitionRx Financials at a Glance
Market Cap
$10.44M
Revenue (TTM)
$2.47M
Net Income (TTM)
-$24.60M
EPS (TTM)
-$4.21
P/E Ratio
-0.29
Dividend
$0.00
Beta (Volatility)
0.75 (Low)
Dividend
$0.00
Beta (Volatility)
0.75 (Low)
Price
$1.22
Volume
4,651
Open
$1.28
Price
$1.22
Volume
4,651
Open
$1.28
Previous Close
$1.22
Daily Range
$1.17 - $1.28
52-Week Range
$1.17 - $18.40
Estimated Earnings Date
May 13, 2026
Dividend
$0.00
Beta (Volatility)
0.75 (Low)
Price
$1.22
Volume
4,651
Open
$1.28
Previous Close
$1.22
Daily Range
$1.17 - $1.28
52-Week Range
$1.17 - $18.40
Estimated Earnings Date
May 13, 2026
VNRX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout VolitionRx
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
75
CEO
Cameron John Reynolds, MBA
Website
www.volition.comHeadquarters
Henderson, NV 89014, US
VNRX Financials
Key Financial Metrics (TTM)
Gross Margin
89.68%
Operating Margin
-870.98%
Net Income Margin
-997.46%
Return on Equity
74.16%
Return on Capital
N/A
Return on Assets
-272.21%
Earnings Yield
-3.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.44M
Shares Outstanding
8.63M
Volume
4.65K
Avg. Volume
407.65K
Financials (TTM)
Gross Profit
$2.21M
Operating Income
-$21.48M
EBITDA
-$20.60M
Operating Cash Flow
-$20.51M
Capital Expenditure
-$95.79K
Free Cash Flow
-$20.60M
Cash & ST Invst.
$3.10M
Total Debt
$11.42M
VolitionRx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$985.08K
+299.8%
Gross Profit
$730.67K
+196.6%
Gross Margin
74.17%
N/A
Market Cap
$10.44M
N/A
Market Cap/Employee
$139.19K
N/A
Employees
75
N/A
Net Income
-$6.66M
-22.9%
EBITDA
-$5.87M
-15.8%
Quarterly Fundamentals
Total Cash
$3.10M
+19.3%
Total Debt
$11.42M
+55.0%
Accounts Receivable
$252.24K
+34.3%
Inventory
$0.00
N/A
Long Term Debt
$6.86M
+10.0%
Short Term Debt
$4.56M
+301.7%
Return on Assets
-2.72%
N/A
Return on Invested Capital
4.46%
N/A
Free Cash Flow
-$5.29M
-23.0%
Operating Cash Flow
-$5.28M
-22.9%